Purchase Order 36C26118P0134
Award Date 10/20/17
Potential Completion Date 9/30/18
Potential Value $416K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
King of Prussia, PA 19406, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to CSL Behring L.L.C., a global biotherapeutics company, to provide the Hereditary Angioedema treatment HAEGARDA. The $174,148.50 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The contract has no set-aside designation and the place of performance is CSL Behring's facility...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order to CSL Behring L.L.C. for the supply of HAEGARDA medication, a treatment for Hereditary Angioedema. The $104,510.10 firm fixed price award was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The contract has no set-aside designation and the place of performance is CSL Behring's facility in King of Prussia, Pennsylvania. CSL...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., a global biotherapeutics company, to provide the Hereditary Angioedema treatment HAEGARDA. The $103,831.50 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA and General Services Administration (GSA). The contract does not have a set-aside designation. The delivery order is part of a...
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a firm fixed price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to CSL Behring L.L.C., a global biotherapeutics company, for the supply of HAEGARDA, a treatment for Hereditary Angioedema. The $159,520.06 order was placed by VA's Veterans Integrated Service Network 22 with a completion date of November 25, 2019. CSL Behring, the prime contractor, has provided specialty...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price delivery order to CSL Behring L.L.C., a global biotherapeutics company, to provide the Hereditary Angioedema treatment HAEGARDA. The $100,329.12 award was made against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration, which allows VA facilities to efficiently procure pharmaceuticals through task orders. The delivery order was placed...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $208,978.20 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA and General Services Administration. The contract is to provide the Hereditary Angioedema treatment medication HAEGARDA to VA medical...
- The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 22, awarded a $153,282.20 firm fixed-price delivery order to CSL Behring L.L.C. for the Hereditary Angioedema treatment HAEGARDA. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, which allows federal agencies to efficiently procure pharmaceuticals through task orders. The contract has...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $152,275.80 firm fixed price order was made against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The order is for the supply of HAEGARDA, a treatment for Hereditary Angioedema, to the VA Greater Los Angeles Healthcare...
- This is a delivery order awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. for the supply of 72 units of the pharmaceutical product HAEGARDA (a C1 inhibitor for hereditary angioedema). The contract has a firm fixed price of $87,207.54 and an ultimate completion date of April 28, 2021. This delivery order was placed against CSL Behring's primary Federal Supply Schedule contract for Pharmaceuticals and...
- This federal contract award to CSL Behring L.L.C., doing business as CSL Behring LLC, is for the delivery of HAEGARDA, a drug used to treat Hereditary Angioedema, to the Department of Veterans Affairs (VA) Veterans Health Administration. The $195,086.00 firm fixed price award was made through the Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration (GSA). The contract has no set-aside designation. This award is associated with a $17.5...